Hologic, Inc.
Hologic is a global medical technology company dedicated to improving women’s health, with a core focus on early detection and proactive treatment, encapsulated in their “Science of Sure” approach. The company is consistently identified as a leading player in the breast imaging market. Hologic’s comprehensive portfolio includes advanced digital and film-based mammography systems, magnetic resonance imaging systems, and critical computer-aided detection (CAD) software. A major innovation is their AI-powered mammography technology, which, in clinical studies, has been shown to aid in detecting more breast cancers and flagging cases initially interpreted as negative. Key products include the 3DQuorum® Imaging Technology, and the Affirm® suite of breast biopsy guidance systems and the ATEC® Breast Biopsy System. Hologic’s technology aims to increase sensitivity, improve results, and enhance the overall standard of care in breast diagnostics and intervention, making them a significant force in transforming breast care globally.
Latest Market Research Report on Breast Imaging Download PDF Brochure Now
GE Healthcare
GE HealthCare is a globally recognized pioneer in the breast care pathway, having introduced Mammography in 1965. The company’s total breast care portfolio spans a wide range of imaging solutions for diagnostic work-ups. GE HealthCare is a top company in the breast imaging market, providing systems that cover molecular imaging, ultrasound, and magnetic resonance imaging technologies. The company is noted for its industry-first innovations, including Automated Breast Ultrasound (ABUS), Contrast Mammography, Contrast Biopsy, and Patient-Assisted Compression features. Their solutions are designed to deliver cost-effective and exceptional care by streamlining processes and strengthening clinical confidence. GE HealthCare continues to integrate breakthrough AI tools and advanced features into its technology, enabling early detection and predictive analytics to visualize all types of breast lesions and tissue, including dense breasts, and improve patient outcomes globally.
Siemens Healthineers
Siemens Healthineers is a leading global medical technology company providing innovative solutions for the healthcare sector, with a strong presence in diagnostic and therapeutic screening, including breast imaging. The company is ranked among the top global players in the breast imaging market. Siemens Healthineers is committed to advancing women’s health through technological innovation, such as the recent launch of 3D mammography with Artificial Intelligence, known as Transpara AI. This AI-powered software uses machine learning algorithms to highlight areas of concern, suggest potential abnormalities, and help prioritize cases based on risk factors, aiming to reduce human error and increase efficiency. Furthermore, their offerings include advanced systems like the FDA-approved Mammomat B. brilliant mammography system, which utilizes tomosynthesis (3D breast imaging) to enhance breast cancer detection with clearer images compared to 2D mammograms. The company’s solutions support personalized diagnostics and improved patient outcomes through highly precise and advanced imaging capabilities.
RadNet
RadNet is the largest provider of freestanding, fixed-site outpatient diagnostic imaging in the United States, operating over 400 centers across multiple states. It plays a significant role in breast imaging by offering services like MRI, Ultrasound, and 3D Mammography (breast tomosynthesis). RadNet is advancing imaging through innovation and technology, specifically in breast care, through its subsidiary DeepHealth, which develops artificial intelligence for mammography interpretation. DeepHealth’s flagship product, Saige-Dx™ (part of the Breast Suite), automatically identifies suspicious lesions and prioritizes cases, helping radiologists interpret mammograms more accurately and efficiently. Additionally, RadNet operates the Breastlink network of comprehensive breast disease management centers, providing specialized breast imaging, biopsy, surgery, and a patient-centered, multi-disciplinary team approach to care, complete with trained navigators. This vertically integrated model positions RadNet as a major force in both diagnostic and therapeutic breast care.
Solis Mammography
Solis Mammography is recognized as one of the country’s leading authorities on 3D mammography and a top imaging center corporation, specializing in a comfortable, patient-focused approach to breast screening. The company is dedicated to mammography innovation, emphasizing both comfort and accuracy in its services. Solis developed the SmartCurve mammogram, which features a unique curved surface designed to be more comfortable than traditional mammograms, significantly reducing patient-reported pain while being paired with highly accurate 3D technology (tomosynthesis). This combination increases the early detection of invasive breast cancer and decreases callbacks. Solis also utilizes Artificial Intelligence (AI) to find breast cancer even earlier, continuously working to improve the patient experience, educate, and inform on breast health. By focusing on cutting-edge technology like 3D and AI, combined with compassionate, patient-friendly care, Solis Mammography is a key leader in the diagnostic breast imaging space.
Seno Medical
Seno Medical is an innovative medical technology company focused on the next evolution of breast cancer diagnostics with its proprietary Imagio® Breast Imaging System. This system represents a significant alternative in the diagnostic pathway by providing real-time images of both functional and anatomic features to differentiate malignant tissue. The core technology is non-invasive opto-acoustic imaging, which utilizes laser light and sound to provide diagnostic confidence earlier in the care pathway. The Imagio® system is paired with the proprietary SenoGram® AI decision support, which assists radiologists in classifying the likelihood of malignancy with greater precision and accuracy. Seno Medical’s approach aims to reduce the financial and emotional burden on women by potentially reducing the need for negative biopsies. By integrating cutting-edge opto-acoustic technology with AI, Seno Medical provides a powerful tool that enhances diagnostic precision and efficiency in the breast imaging landscape.
Koninklijke Philips N.V.
Koninklijke Philips N.V., a global leader in health technology, is consistently ranked among the top companies in the breast imaging market. The company provides a range of innovative solutions that support the entire breast care continuum, from screening and diagnosis to treatment planning. Philips’ offerings in breast imaging typically encompass advanced mammography systems, including 3D breast tomosynthesis, ultrasound, and magnetic resonance imaging (MRI) tailored for breast health. By focusing on integrated technology and informatics, Philips aims to enhance clinical confidence, improve workflow efficiency for clinicians, and deliver a more comfortable and personalized experience for patients. The company’s commitment to delivering integrated solutions and high-quality medical imaging technologies solidifies its position as a key global player in driving advancements in breast cancer detection and diagnosis.
FUJIFILM Holdings Corporation
FUJIFILM Holdings Corporation is a major global technology company with a significant presence in the medical imaging sector, including breast imaging. The company is listed as one of the top players in both the United States and global mammography markets. FUJIFILM’s dedication to healthcare is centered on providing high-quality diagnostic imaging solutions that contribute to early disease detection. Its product portfolio in breast imaging includes advanced digital mammography systems and related imaging technologies. The company leverages its expertise in image processing and digital technology to develop solutions that offer superior image clarity and diagnostic precision for radiologists. By continuously innovating in imaging systems, FUJIFILM supports healthcare professionals in streamlining workflows and improving the accuracy of breast cancer screening and diagnosis, maintaining its position as an influential provider of medical imaging infrastructure.
SimonMed Imaging
SimonMed Imaging is one of the largest physician-owned radiology providers and a top imaging center corporation in the U.S., noted for having a high number of FDA MQSA-accredited facilities for mammography. The company is committed to offering the most advanced imaging options, including 3D mammography, breast ultrasounds, and breast MRIs, at affordable and accessible centers. SimonMed’s pioneering approach is highlighted by its **Mammogram+** offering, which is the first mammogram to use two advanced Artificial Intelligence (AI) technologies together. This dual-AI system is designed to spot subtle signs of cancer earlier and with greater accuracy, especially in dense breast tissue, by quickly analyzing images for malignant soft tissue densities and calcifications. This personalized, AI-enhanced approach, combined with a focus on patient experience through its digital health platform, positions SimonMed as a leader in applying cutting-edge technology for enhanced breast cancer detection and patient empowerment.
Latest Market Research Report on Breast Imaging Download PDF Brochure Now